Benefits and drawbacks of combining in-vacuo/solution methylation with ESI-DMS-MS analysis are demonstrated in studies with the peptides pentaalanine and [Glu1] fibrinopeptide B. Methylation introduces a quaternary ammonium at the N-terminus of the peptide and changes the number of protonation sites. This has allowed the comparative quantification of sensitivity and selectivity with and without methylation. The transformation of the protonation site in pentaalanine to a quaternary ammonium was observed to reduce DMS selectivity and this was attributed to a weaker ion/modifier interaction. On the other hand, sensitivity was increased and this was attributed to the elimination of ion loss by proton transfer to the modifier. Methylation of [Glu1] fibrinopeptide B was observed not to change the charge state as one protonation site is displaced by a quaternary ammonium. Sensitivity was increased due to suppression of proton transfer to the modifier. Selectivity was not significantly affected in this case as ion/modifier interaction was maintained through the additional protonation site. Our study was conducted with 5 different modifiers and some of their mixtures.